FDA Approved: SUSTOL — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SUSTOL (granisetron) from Heron Therapeutics, Inc. The action concerns regulatory approval related to this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SUSTOL (granisetron)

Snippet

SUPPL AP for SUSTOL (GRANISETRON)